Emerald Health Therapeutics

60+ Years of Cannabis Growing Experience

/
Volume | Market Cap | Shares | PEG Ratio | EPS

Fundamentals.

Location:
HQ: Victoria, British Columbia
Incorporated: originally T-Bird Pharma Inc
Symbol: EMHTF on OTC
Facilities: Vancouver, BC; Delta BC (50% owned); Quebec
Exchanges: TSX, OTC. Frankfurt
Licenses: production and sales

CEO: Chris Wagner

Focus: Neutral (nothing unusual to set it apart)

Size:
Market Cap: $392 mil
Enterprise Value: $311 mil
Size within cannabis industry: About 12th of 200+
Size among cultivators: 6th of about 40
# of employees: 24

Markets: Neutral
Primary: Initially British Columbia (has facilities there) and Quebec (just bought facilities there from Agro-Biotech).
Secondary: Later, all Canada, and beyond, especially through Namaste created ecommerce platform.

Subsidiaries, Interests: Strong  (good partnerships)

Operations: Neutral

Cultivation: Neutral

Distribution: Weak (behind the curve)

Integration/Diversification: Neutral
Vertically integrated: yes they produce and will eventually sell through online platform.
Horizontally diversified: eventually perhaps yes, with medical and blockchain pursuits.

Financials: Weak (still very low revenue)

Management: Strong

Branding: Neutral to Strong

Valuation: Weak (too high given state of production)

Recommendation: Neutral

Get the Q1, ’19 Cannin Report ($99)

Includes the latest market & industry update, 12 technical fundamental analyses, latest regulations by state, new medical research and more!

LEARN MORE

Technicals.

READ EMERALD NEWS